Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences-Reference-Cited by-同舟云学术

Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences

Published:2018-10 Issue:7 Volume:119 Page:832-839
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Kruger Dinja T.,Beelen Karin J.,Opdam Mark,Sanders Joyce,van der Noort Vincent,Boven Epie,Linn Sabine C.

Funder

This work was supported by grants from TI Pharma (project number T3-502) and from A Sister’s Hope.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-018-0221-8.pdf

Reference44 articles.

1. Saini, K. S. et al. Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer. Cancer Treat. Rev. 39(8), 935–946 (2013).

2. Ciruelos Gil, E. M. Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer. Cancer Treat. Rev. 40(7), 862–871 (2014).

3. Osborne, C. K. & Schiff, R. Mechanisms of endocrine resistance in breast cancer. Annu. Rev. Med. 62, 233–247 (2011).

4. Nardone, A., De Angelis, C., Trivedi, M. V., Osborne, C. K. & Schiff, R. The changing role of ER in endocrine resistance. Breast 24, (Suppl 2), S60–S66 (2015).

5. Miller, T. W., Balko, J. M. & Arteaga, C. L. Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer. J. Clin. Oncol. 29(33), 4452–4461 (2011).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes;Cell Reports Medicine;2024-06

2. Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer;ESMO Open;2024-03

3. Targeting fatty acid uptake and metabolism in cancer cells: A promising strategy for cancer treatment;Biomedicine & Pharmacotherapy;2023-11

4. Fatty Acid Synthase Mutations Predict Favorable Immune Checkpoint Inhibitor Outcome and Response in Melanoma and Non-Small Cell Lung Cancer Patients;Cancers;2022-11-17

5. Advances in Analyzing the Breast Cancer Lipidome and Its Relevance to Disease Progression and Treatment;Journal of Mammary Gland Biology and Neoplasia;2021-12-16